Seeking Alpha
Long/short equity, contrarian, short-term horizon, dividend investing
Profile| Send Message|
( followers)  

<< Back to Part III

This is Part IV of earnings being reported on Monday (it is going to be VERY busy day indeed). There are quite a few market moving stocks reporting earnings. The stocks listed are not those reporting, but stocks I believe are worth watching for a trade, investment, and / or to gauge market sentiment. It is easy to see we are in the middle of earnings season when it takes this many parts to go over the biggest companies reporting in one day.

Mindspeed Technologies, Inc (MSPD) is a $247.81 million market cap company. Mindspeed Technologies, Inc. (Mindspeed) designs, develops and sells semiconductor solutions for communications applications in the wireline and wireless network infrastructure, which includes enterprise networks, broadband access networks (fixed and mobile), and metropolitan and wide area networks (WAN).

The company reported $-0.02 per share in earnings for the quarter ending April 1, 2011. The Quick Ratio is 2.4. The next reporting quarter estimated mean earnings are $0.03 per share. Analyst estimates range between $0.02 and $0.03 per share.

The current trailing twelve months (ttm) P/E ratio is 12.81 and the forward P/E ratio is 16.89. A rising P/E ratio is usually not what we want to see for an investment.The stock has a price to book ratio (ttm) of 4.34. The price to sales ratio is 1.5.

In the last month the stock has moved in price -10.29%, with a one year change of -14.71%. Comparing to the S&P500 price change, Mindspeed Technologies, Inc.'s performance is 3.06% vs. the S&P 500 from a month ago, and the one year difference is 3.74% vs. S&P 500 price change.

The annual growth rate of revenue is 40.8%. The last fiscal year had accounts receivable to sales percentage of 0.1441% compared to the same period a year earlier of 0.0605%.

Mindspeed Technologies, Inc. has rising revenue year-over-year of $178.18 million for 2010 vs. $126.55 million for 2009. The bottom line has rising earnings year-over-year of $21.07 million for 2010 vs. $-25.11 million for 2009. The company's earnings before income and taxes are rising with an EBIT year-over-year of $22.87 million for 2010 vs. $-22.56 million for 2009.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-11 0 0.01 0.01 614.29%
Dec-10 0.06 0.09 0.03 43.08%
Sep-10 0.31 0.46 0.15 46.82%
Jun-10 0.15 0.18 0.03 17.42%
Mar-10 0.11 0.15 0.04 38.89%

Netflix Inc (NFLX) is a $14.48 billion market cap company. Netflix, Inc. (Netflix) is an Internet subscription service streaming television shows and movies. The company’s subscribers can watch unlimited television shows and movies streamed over the Internet to their televisions, computers and mobile devices and in the United States, subscribers can also receive digital versatile discs (DVDs) delivered to their homes. The company is organized into two operating segments: United States and International. The company obtains content from various studios and other content providers through fixed-fee licenses, revenue sharing agreements and direct purchases. The company markets its service through various channels, including online advertising, broad-based media, such as television and radio, as well as various partnerships. In September 2010, the company began international operations by offering an unlimited streaming plan without DVDs in Canada.

The company reported $1.14 per share in earnings for the quarter ending March 31, 2011. The Quick Ratio is 1.65
The next reporting quarter estimated mean earnings are $1.11 per share. Analyst estimates range between $1.02 and $1.17 per share.

The current trailing twelve months (ttm) P/E ratio is 79.583 and the forward P/E ratio is 41.34. The falling P/E ratio is the result of future earnings increasing relative to the current price and suggests bullishness in the company by analysts.The stock has a price to book ratio (ttm) of 32.88. The price to sales ratio is 4.41.

In the last month the stock has moved in price 14.59%, with a one year change of 22.13%. Comparing to the S&P500 price change, Netflix Inc.'s performance is 5.56% vs. the S&P 500 from a month ago, and the one year difference is 8.15% vs. S&P 500 price change.

The annual growth rate of revenue is 29.48%. Speaking of revenue growth rate, I believe this will be the one to watch with Netflix. I have been going negative in the chat room with this stock and I will try to have my article on it before the bell on Tuesday. Longer term I am near or at bearish. That is not easy to do either, I love the service (well, I like it anyway). The chart looks good though. The moving averages are moving up nicely in step. The price is holding up and seeing 300 again appears to be a real possibility. Few people do this, but take a look at the weekly and especially the monthly chart. The monthly says it all when combined with the PE ratio. Absent some very material improvement in earnings, this stock is headed much lower in my opinion. It is not a matter of if, but when. Of course, the 'when' part is just as important as the 'if'. Based on a Tom Demark study of the monthly chart it appears that Netflix has some very real downside risk in the next month or two. Tom Demark is the greatest market timer that I know of, and while he doesn't have a crystal ball (you don't have one right Tom?), he often gives the appearance that he does based on some of his indicators.

Netflix Inc. has rising revenue year-over-year of $2.16 million for 2010 vs. $1.67 million for 2009. The bottom line has rising earnings year-over-year of $160.85 million for 2010 vs. $115.86 million for 2009. The company's earnings before income and taxes are rising with an EBIT year-over-year of $283.64 million for 2010 vs. $191.94 million for 2009. The company does not currently pay a dividend.

Buying some portfolio insurance may not be the worst idea for those that own this stock going into earnings. The flip side is to sell calls against the stock you own to try to capture some on the high premium but that is normally best left to the professionals. Best of luck with this one going into earnings, and I can say for sure that I will be watching Netflix, both during and after trading hours...

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-11 1.07 1.11 0.04 3.47%
Dec-10 0.71 0.87 0.16 22.28%
Sep-10 0.71 0.7 0.01 1.84%
Jun-10 0.7 0.8 0.1 13.65%
Mar-10 0.55 0.59 0.04 8%

Nuvasive Inc (NUVA) is a $1.32 billion market cap medical device company. NuVasive focuses on developing minimally disruptive surgical products and procedures for the spine. During the year ended December 31, 2010, it marketed a product portfolio focused on applications for spine fusion surgery, including biologics.

The company reported $0.06 per share in earnings for the quarter ending March 31, 2011. The Quick Ratio is 2.42. The next reporting quarter estimated mean earnings are $0.17 per share. Analyst estimates range between $0.14 and $0.2 per share.

The current trailing twelve months (ttm) P/E ratio is 17.681 and the forward P/E ratio is 34.63. A rising P/E ratio is usually not what we want to see for an investment.The stock has a price to book ratio (ttm) of 2.69. The price to sales ratio is 2.44.

In the last month the stock has moved in price -0.29%, with a one year change of -0.32%. Comparing to the S&P500 price change, Nuvasive Inc.'s performance is 7.73% vs. the S&P 500 from a month ago, and the one year difference is 10.4% vs. S&P 500 price change.

The annual growth rate of revenue is 29.13%. The last fiscal year had accounts receivable to sales percentage of 0.1602% compared to the same period a year earlier of 0.1579%.

Nuvasive Inc. has rising revenue year-over-year of $478.24 million for 2010 vs. $370.34 million for 2009. The bottom line has rising earnings year-over-year of $78.29 million for 2010 vs. $5.81 million for 2009. The company's earnings before income and taxes are rising with an EBIT year-over-year of $32.09 million for 2010 vs. $11.32 million for 2009.

The chart looks better than average and the earnings beats really look impressive. This is one of those stocks that normally flies under the radar and worth a second look. The stock is very thin, but that lack of trading volume may spell some opportunity for those that feel this would be a good investment fit for a longer term hold. I added this one to my screener and will take another look after earnings. If the earnings maintain the pace I will look for a long entry on a dip in price. Keeping a close eye on how the 200 day moving average performs is a good idea as well. The faster moving averages just crossed to the upside of the 200MA, but the longer moving average may start to fade downward.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-11 0.19 0.24 0.05 25.98%
Dec-10 0.42 0.46 0.04 9.52%
Sep-10 0.42 0.46 0.04 9.03%
Jun-10 0.28 0.42 0.14 51.24%
Mar-10 0.09 0.21 0.12 129.76%

Owens & Minor Inc. (OMI) is a $2.22 billion market cap distributor of medical and surgical supplies to the acute-care market. The company is engaged in providing distribution and other supply-chain management services to healthcare providers and suppliers of medical and surgical products. Its service consists of the distribution of finished medical and surgical products procured from over 1,200 suppliers to approximately 4,400 healthcare providers from 52 distribution and service centers. In serving the company’s healthcare customers, including acute-care and alternate-site providers and healthcare products suppliers, it also provides a range of data analysis tools and outsourced resource management and consulting services, such as inventory, supply spending and contract management. Distribution of medical and surgical supplies to healthcare providers, including its MediChoice private label product line, accounts for over 95% of the company’s revenues during the year ended December 31, 2010.

The company reported $0.45 per share in earnings for the quarter ending March 31, 2011. The Quick Ratio is 0.98. The next reporting quarter estimated mean earnings are $0.49 per share. Analyst estimates range between $0.48 and $0.52 per share.

The current trailing twelve months (ttm) P/E ratio is 19.659 and the forward P/E ratio is 15.52. The falling P/E ratio is the result of future earnings increasing relative to the current price and suggests bullishness in the company by analysts. The stock has a price to book ratio (ttm) of 2.17. The price to sales ratio is 0.23.

In the last month the stock has moved in price 4.21%, with a one year change of 29.28%. Comparing to the S&P500 price change, Owens & Minor Inc.'s performance is -0.47% vs. the S&P 500 from a month ago, and the one year difference is 2.9% vs. S&P 500 price change.

The annual growth rate of revenue is 1.07%. The last fiscal year had accounts receivable to sales percentage of 0.0581% compared to the same period a year earlier of 0.062%. For the trailing twelve months investors received $0.71 in dividends for a yield of 2.29%.

Owens & Minor has rising revenue year-over-year of $8.12 million for 2010 vs. $8.04 million for 2009. The bottom line has rising earnings year-over-year of $110.58 million for 2010 vs. $104.66 million for 2009. The company's earnings before income and taxes are falling with an EBIT year-over-year of $195.94 million for 2010 vs. $201.28 million for 2009.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-11 0.47 0.45 0.02 4.03%
Dec-10 0.51 0.53 0.02 4.13%
Sep-10 0.49 0.5 0.01 2.44%
Jun-10 0.49 0.46 0.03 5.56%
Mar-10 0.43 0.44 0.01 1.24%

Plum Creek Timber Co Inc (PCL) is a $6.67 billion market cap timberland owner in the United States. As of December 31, 2010, it owned 6.8 million acres of timberlands located in 19 states. Its timberlands are diversified, not only geographically, but also by species mix and age distribution. It manages its timberlands in two segments: the Northern Resources Segment, consisting of timberlands in Maine, Michigan, Montana, New Hampshire, Oregon, Vermont, Washington, West Virginia and Wisconsin, and the Southern Resources Segment, consisting of timberlands in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, Oklahoma, South Carolina and Texas.

The company reported $0.23 per share in earnings for the quarter ending March 31, 2011. The Quick Ratio is 0.96. The next reporting quarter estimated mean earnings are $0.29 per share. Analyst estimates range between $0.26 and $0.32 per share.

The current trailing twelve months (ttm) P/E ratio is 44.043 and the forward P/E ratio is 24.98. The falling P/E ratio is the result of future earnings increasing relative to the current price and suggests bullishness in the company by analysts. The stock has a price to book ratio (ttm) of 4.42. The price to sales ratio is 5.11.

In the last month the stock has moved in price 4.65%, with a one year change of 14.7%. Comparing to the S&P500 price change, Plum Creek Timber Co Inc.'s performance is -0.05% vs. the S&P 500 from a month ago, and the one year difference is -8.71% vs. S&P 500 price change.

The annual growth rate of revenue is -8.04%. The last fiscal year had accounts receivable to sales percentage of 0.0193% compared to the same period a year earlier of 0.0301%. For the trailing twelve months investors received $1.68 in dividends for a yield of 4.08%.

Click to enlarge


Plum Creek Timber Co Inc. has falling revenue year-over-year of $1.19 million for 2010 vs. $1.29 million for 2009. The bottom line has falling earnings year-over-year of $213.00 million for 2010 vs. $236.00 million for 2009. The company's earnings before income and taxes are falling with an EBIT year-over-year of $297.00 million for 2010 vs. $299.00 million for 2009.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-11 0.24 0.23 0.01 3.81%
Dec-10 0.44 0.45 0.01 2.46%
Sep-10 0.24 0.2 0.04 16.81%
Jun-10 0.15 0.21 0.06 37.89%
Mar-10 0.38 0.47 0.09 25.17%

Qiagen Nv (QGEN) is a $4.19 billion market cap holding company, which provides technologies and products for preanalytical sample preparation and linked molecular assay solutions. The company has developed a portfolio of more than 500 consumable products and automated solutions for sample collection, and nucleic acid and protein handling, separation, and purification, as well as open and target-specific assays. The Quick Ratio is 3.19

The current trailing twelve months (ttm) P/E ratio is 29.233 and the forward P/E ratio is 16.36. The falling P/E ratio is the result of future earnings increasing relative to the current price and suggests bullishness in the company by analysts. The stock has a price to book ratio (ttm) of 1.9. The price to sales ratio is 4.32.

In the last month the stock has moved in price 3.78%, with a one year change of 4.16%. Comparing to the S&P500 price change, Qiagen Nv's performance is 1.65% vs. the S&P 500 from a month ago, and the one year difference is 1.94% vs. S&P 500 price change.

The annual growth rate of revenue is 133.47%. The last fiscal year had accounts receivable to sales percentage of 0.1916% compared to the same period a year earlier of 0.2046%. Qiagen Nv has rising revenue year-over-year of $1.09 million for 2010 vs. $1.01 million for 2009. The bottom line has rising earnings year-over-year of $144.31 million for 2010 vs. $137.77 million for 2009. The company's earnings before income and taxes are rising with an EBIT year-over-year of $188.54 million for 2010 vs. $180.21 million for 2009.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-11 0.2 0.2 0 0.00%
Dec-10 0.25 0.24 0.01 2.76%
Sep-10 0.23 0.24 0.01 4.67%
Jun-10 0.21 0.21 0 0.00%
Mar-10 0.19 0.2 0.01 5.54%

Reinsurance Group Of America Inc (RGA) is a $4.62 billion market cap insurance holding company. The company is engaged in traditional life and health for individual and group coverages, annuity, critical illness and financial reinsurance. During the year ended December 31, 2010, the company’s operations in the United States and Canada contributed approximately 69% of its consolidated net premiums.

The company reported (basic) $2.2 per share in earnings for the quarter ending March 31, 2011. The next reporting quarter estimated mean earnings are $1.82 per share. Analyst estimates range between $1.77 and $1.88 per share.

The current trailing twelve months (ttm) P/E ratio is 7.581 and the forward P/E ratio is 7.99. A rising P/E ratio is usually not what we want to see for an investment. The stock has a price to book ratio (ttm) of 0.8. The price to sales ratio is 0.49.

In the last month the stock has moved 4.2% in price, with a one year change of 35.24%. Comparing to the S&P500 price change, Reinsurance Group Of America Inc.'s performance is -0.48% vs. the S&P 500 from a month ago, and the one year difference is 7.64% vs. S&P 500 price change.

The annual growth rate of revenue is 16.91%. For the trailing twelve months investors received $0.48 in dividends for a yield of 0.77%.


Reinsurance Group Of America Inc has rising revenue year-over-year of $8.26 million for 2010 vs. $7.07 million for 2009. The bottom line has rising earnings year-over-year of $574.40 million for 2010 vs. $407.09 million for 2009. The company's earnings before income and taxes are rising with an EBIT year-over-year of $863.82 million for 2010 vs. $592.35 million for 2009.

Here is a look at reported earnings (may or may not be basic EPS) compared to the mean estimate.
Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-11 1.57 1.61 0.04 2.69%
Dec-10 1.86 2.15 0.29 15.37%
Sep-10 1.66 1.72 0.06 3.75%
Jun-10 1.6 1.63 0.03 1.65%
Mar-10 1.59 1.25 0.34 21.48%



Disclosure: I have no positions in any stocks mentioned, but may initiate a short position in NFLX over the next 72 hours.

Source: 7 Companies to Consider That Are Reporting Earnings Monday, Part IV